From September 20–26, 2022, the vibrant city of Basel, Switzerland—one of Europe’s leading life sciences hubs—became the epicenter of global innovation during the Sachs Autumn Life Sciences Week. This highly anticipated event brought together healthcare executives, investors, entrepreneurs, and thought leaders for a week of intensive discussions, networking, and strategic collaboration focused on the future of health technology and biotechnology investment.
Anchoring Events: HealthTech and Biotech Forums
The week was anchored by two prominent conferences:
- The 9th Annual HealthTech Investment Forum
- The 22nd Annual Biotech in Europe Forum
Each forum served as a cornerstone for industry exchange, attracting C-level executives, venture capitalists, private equity firms, institutional investors, and innovation-driven startups from around the world.
The HealthTech Investment Forum focused on the rapidly evolving landscape of digital health, diagnostics, medical devices, and telehealth. Sessions explored how emerging technologies are reshaping patient care, improving diagnostic accuracy, and expanding access to healthcare services—particularly in light of lessons learned from the COVID-19 pandemic.
Meanwhile, the Biotech in Europe Forum, one of Sachs Associates’ flagship events, emphasized innovation in therapeutics, biopharmaceutical development, and drug discovery. Topics included advancements in oncology, gene therapy, rare diseases, and precision medicine. The forum provided a platform for biotech companies to showcase their pipelines, engage with potential partners, and seek funding opportunities to accelerate development.
A Marketplace for Strategic Partnerships
Sachs Autumn Life Sciences Week is renowned not just for its insightful panels and keynote addresses but for being a deal-making environment. A robust partnering system allowed participants to schedule one-on-one meetings, laying the groundwork for collaborations, licensing agreements, and funding deals. This aspect of the event has made it a must-attend for companies at all stages of growth—from early-stage innovators to established pharmaceutical firms.
Driving Investment and Innovation in Life Sciences
With global challenges such as aging populations, rising healthcare costs, and post-pandemic recovery shaping healthcare priorities, Sachs Autumn Life Sciences Week 2022 served as a timely platform to explore investment trends and innovation strategies. It helped align stakeholders on how to bring impactful technologies to market while navigating regulatory, financial, and ethical complexities.
